Novo Nordisk said it had agreed to license a potential rival to its weight-loss drug Ozempic from a Chinese company. The ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

The researchers found that drug seizures in San Francisco were associated with a substantial increase in fatal opioid ...

Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

(There's also a high failure rate -- 90% of drugs that reach the clinical trial phase never come to market.) For every drug ...

A massive spike in meth use is being linked to a change in global shopping habits - with the market shifting from ...

SEATTLE — An entrenched and escalating drug market is creating chronic public safety issues in Seattle’s University District, according to neighbors and local businesses - and now there is a ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...